Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.

To investigate the role of angiotensin II (Ang II) in hypertension-induced tissue injury, we gave TCV-116 (1 mg/kg per day PO), a nonpeptide Ang II type I receptor antagonist, or enalapril (10 mg/kg per day PO) to deoxycorticosterone acetate (DOCA)-salt hypertensive rats for 3 weeks and examined the effects on tissue mRNA levels for transforming growth factor-beta 1 (TGF-beta 1) and extracellular matrix components. Tissue mRNA levels were measured by Northern blot analysis. Renal mRNA levels for TGF-beta 1; types I, III, and IV collagen; and fibronectin in DOCA-salt hypertensive rats were increased by severalfold (P < .01) compared with sham-operated rats. In the aorta of DOCA-salt hypertensive rats, TGF-beta 1 and fibronectin mRNA levels were increased, but types I, III, and IV collagen mRNAs did not increase. In the heart, increased mRNA was found only for fibronectin. Thus, these gene expressions are regulated in a tissue-specific manner. TCV-116 or enalapril did not lower blood pressure in DOCA-salt hypertensive rats. However, the increase in renal mRNAs for TGF-beta 1 and extracellular matrix components in DOCA-salt hypertensive rats was significantly inhibited by treatment with TCV-116 or enalapril, which was associated with a significant decrease in urinary protein and albumin excretions and histological improvement of renal lesions. In contrast, in the aorta and heart these gene expressions were not affected by TCV-116 or enalapril. Thus, local Ang II may contribute to renal injury of DOCA-salt hypertension by stimulating the gene expression of TGF-beta 1 and extracellular matrix components.

[1]  Rossert Ja,et al.  Regulation of type I collagen synthesis. , 1995, Kidney international. Supplement.

[2]  Y. Yoshimura,et al.  Evaluation and improvement of bioavailability of a new angiotensin II receptor antagonist, 2-butyl-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl-1H-benzimidazole-7-carboxylic acid by making prodrug☆ , 1994 .

[3]  D. de Zeeuw,et al.  Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. , 1993, Kidney international.

[4]  A. Shino,et al.  TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[5]  K. Fuxe,et al.  Cellular expression of angiotensin type-1 receptor mRNA in the kidney. , 1993, Kidney international.

[6]  S. Klahr,et al.  Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. , 1993, Kidney international.

[7]  K. Kubo,et al.  Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  T. Inagami,et al.  Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. , 1993, Kidney international.

[9]  J. Laragh,et al.  Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade , 1993, Journal of hypertension.

[10]  J. Zhuo,et al.  High resolution localization of angiotensin II receptors in rat renal medulla. , 1992, Kidney international.

[11]  A. Chobanian,et al.  Age-related changes in fibronectin expression in spontaneously hypertensive, Wistar-Kyoto, and Wistar rat hearts. , 1992, Circulation research.

[12]  L. Navar,et al.  Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. , 1992, Hypertension.

[13]  J. Laragh,et al.  Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. , 1992, Journal of hypertension.

[14]  M. Hosoi,et al.  Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats. , 1992, Hypertension.

[15]  T. Meyer,et al.  Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. , 1992, The Journal of clinical investigation.

[16]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[17]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[18]  A. Fogo,et al.  Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. , 1992, Kidney international.

[19]  A. Chobanian,et al.  Hypertension induces alternatively spliced forms of fibronectin in rat aorta. , 1992, Hypertension.

[20]  P. Brecher,et al.  Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. , 1992, The Journal of clinical investigation.

[21]  Y. Tomino,et al.  Gene expression of growth-related proteins and ECM constituents in response to unilateral nephrectomy. , 1992, The American journal of physiology.

[22]  P. Brecher,et al.  Fibronectin expression in the normal and hypertrophic rat heart. , 1992, The Journal of clinical investigation.

[23]  M. Sporn,et al.  TGF-beta: regulation of extracellular matrix. , 1992, Kidney international.

[24]  T. Haverty,et al.  Mechanisms of tubulointerstitial fibrosis , 2004, Current opinion in nephrology and hypertension.

[25]  D. Campbell,et al.  Differential Regulation of Angiotensin Peptide Levels in Plasma and Kidney of the Rat , 1991, Hypertension.

[26]  D. de Zeeuw,et al.  Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. , 1991, Kidney international.

[27]  J. Ingelfinger,et al.  Molecular biology of renal injury: emphasis on the role of the renin-angiotensin system. , 1991, Journal of the American Society of Nephrology : JASN.

[28]  N. Kikuchi,et al.  Amino-terminal amino acid sequence and heterogeneity in glycosylation of rat renal renin. , 1991, The Journal of biological chemistry.

[29]  J. Noh,et al.  Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. , 1991, The American journal of pathology.

[30]  A. Chobanian,et al.  Effect of hypertension on fibronectin expression in the rat aorta. , 1990, The Journal of biological chemistry.

[31]  R. Carey,et al.  Angiotensin II regulates renin gene expression. , 1990, The American journal of physiology.

[32]  M. Seikaly,et al.  Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. , 1990, The Journal of clinical investigation.

[33]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[34]  H. Moses,et al.  The cell biology of transforming growth factor β , 1990 .

[35]  A. Roberts,et al.  cDNA cloning by PCR of rat transforming growth factor beta-1. , 1990, Nucleic acids research.

[36]  M. Hosoi,et al.  Modification of glycosylation of renin in sodium-depleted and captopril-treated rats. , 1989, The American journal of physiology.

[37]  A. Chobanian,et al.  Growth factor expression in aorta of normotensive and hypertensive rats. , 1989, The Journal of clinical investigation.

[38]  W. Stead,et al.  Progression of renal insufficiency: role of blood pressure. , 1989, Kidney international.

[39]  C. Stier,et al.  Enalapril Prevents Stroke and Kidney Dysfunction in Salt‐Loaded Stroke‐Prone Spontaneously Hypertensive Rats , 1989, Hypertension.

[40]  S. Klahr,et al.  The progression of renal disease. , 1989, The New England journal of medicine.

[41]  K. Yamamoto,et al.  Importance of glycosylation for hepatic clearance of renal renin. , 1988, The American journal of physiology.

[42]  H. Iwao,et al.  Sodium balance effects on renin, angiotensinogen, and atrial natriuretic polypeptide mRNA levels. , 1988, The American journal of physiology.

[43]  Vicotor J Dzau,et al.  Circulating versus local renin‐angiotensin system in cardiovascular homeostasis , 1988, Circulation.

[44]  A. Fukamizu,et al.  Structure of the rat renin gene. , 1988, Journal of molecular biology.

[45]  H. Iwao,et al.  Cellular and subcellular distribution of exogenously administered renal renin in rat liver and kidney. , 1987, The American journal of physiology.

[46]  D. de Zeeuw,et al.  Reduction of proteinuria by angiotensin converting enzyme inhibition. , 1987, Kidney international.

[47]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[48]  B. Brenner,et al.  Reversing glomerular hypertension stabilizes established glomerular injury. , 1987, Kidney international.

[49]  K. Kohno,et al.  Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeats. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Hunt,et al.  Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. , 1986, Hypertension.

[51]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.

[52]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[53]  R. Glanville,et al.  Amino acid sequence of the non-collagenous globular domain (NC1) of the alpha 1(IV) chain of basement membrane collagen as derived from complementary DNA. , 1985, European journal of biochemistry.

[54]  Y. Yamada,et al.  Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. , 1985, The Journal of biological chemistry.

[55]  D. Rowe,et al.  Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. , 1984, Biochemistry.

[56]  R. Hynes,et al.  Three different fibronectin mRNAs arise by alternative splicing within the coding region , 1983, Cell.

[57]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[58]  C. Henderson,et al.  Role of WHO. , 1982, Experientia. Supplementum.